• Summarize what previous studies have shown about the effectsparticularly on the risk of various malignancies-of exposure to polychlorinated biphenyls (PCBs) and other persistent organic pollutants (POPs).
P
rostate cancer is the most common malignancy in Western society. 1, 2 In Sweden, 9030 men were diagnosed in 2003, and the lifetime risk of being diagnosed with prostate cancer is 16%. During the last 10-year time period, the age-standardized incidence increased by 4% annually, 3 mainly because of increased prostate specific antigen (PSA) testing. However, a real increase in incidence, as the result of unrevealed exposures, cannot be excluded.
The etiology of prostate cancer is poorly understood. Besides age, family history, and ethnicity, there are no established risk factors. An increased risk has been associated with use of pesticides 4 and higher incidence and mortality has been found among farmers. [5] [6] [7] Few studies have investigated an association between persistent organic pollutants (POPs) and prostate cancer. In one study, the serum concentration of polychlorinated biphenyl (PCB) was positively associated with the risk of prostate cancer. 8 Indeed, in a further analysis, it was found that the odds ratio (OR) more than doubled among men with the highest concentration of moderately chlorinated PCBs in comparison with the lowest concentrations. 9 POPs such as PCBs are fat-soluble chemicals that bioaccumulate in the human body. An increased risk for non-Hodgkin lymphoma has been indicated for PCBs, 10 -12 possibly mediated by immunotoxic effects. 13, 14 Several POPs are endocrine disrupters, exerting estrogen and androgen activity with adverse effects on male reproduction. 15 The estrogenic and androgenic activity may act both as agonist or as an antagonist. 15, 16 Sex steroid hormones are required for normal growth and function of the prostate. 17 It also has been proposed that they may be involved in development of prostate cancer. Moreover, prostate cancer mostly responds to hormonal manipulation. As POPs exert endocrine effects it seems reasonable to investigate their association with prostate cancer. The aim of this study was to compare the adipose tissue concentrations of POPs in patients with a newly diagnosed prostate cancer and hospital based controls undergoing transuretral resection for benign prostate hyperplasia.
Materials and Methods
The study was approved by the local ethical committee. The study population consisted of all men living in the county of Ö rebro between 1997 and 1999. There were no private urologists, and no prostate cancer screening took place during this time period. All men suspected to have prostate cancer were referred to the University Hospital, Ö rebro for further diagnostic work up. Eligible as cases were all men with a newly diagnosed prostate cancer, verified either histopathologically or cytologically. All tumors were staged according to the UICC TNM classification and graded by the WHO or the Gleason grading system.
Patients undergoing transuretral resection for presumed benign hyperplasia were selected as controls. One reason for selecting hospitalbased controls was to get a homogenous control group with similar age distribution as the cases. Moreover, the procedure of obtaining fat tissue sample was facilitated because these patients already undergone anesthesia for their transuretral resection (spinal anesthesia). All study subjects were included by the same urologist (S.-O. Andersson). After informed consent, adipose tissue biopsy was taken from the abdominal wall from both cases and controls. This method was the most appropriate one under the clinical circumstances. The study subjects were recruited during the time period 1997 to 1999.
Adipose tissue was used to enlarge the sample mass of lipid to be able to also determine toxic equivalent factor (TEQ) if decided. Because of the high cost, dioxins and dibenzofurans were not analyzed. The concentrations of these POPs are expressed in picograms per gram of lipid and would require a large amount of blood to be determined if used instead of adipose tissue. However, for the now-analyzed POPs in nanograms per gram of lipid concentrations, it would be possible to draw blood for analysis. Concentrations on lipid basis of organochlorines and dioxin-like compounds are comparably determined in any lipidcontaining human tissue.
The adipose tissue samples were given a unique id number, and during all chemical analyses it was unknown to the investigator whether the sample was derived from a case or a control subject. Tissue samples were collected from a total of 81 subjects (58 cases and 23 controls). After the chemical analysis (see the section "Chemical Analysis"), histopathology was reviewed for all included subjects. Three controls were excluded since they had a malignant disease.
All study subjects answered a questionnaire, which included questions on occupations, chemical exposures, family history of cancer, height, present weight, and weight 1 year before diagnosis. Body mass index (BMI) was calculated. Clinical parameters were obtained from records including histopathological differentiation (Gleason score), nuclear grade (WHO), and PSA.
Chemical Analysis
Approximately 1 g of the samples was homogenized with Na 2 SO 4 and fortified with 13 C-labeled internal PCB and pesticide standards. The compounds of interest were extracted from the tissue homogenates by supercritical fluid extraction using CO 2 as extraction media. 18 In addition, one laboratory blank sample and one reference sample of each set of eight samples were analyzed. The lipid content of each sample was determined gravimetrically from a subsample. Congener specific analysis and quantification of PCBs, polybrominated diphenylethers (PBDEs), chlordanes (cis-heptachlorepoxide, trans-chlordane, oxychlordane, metabolic compound 6 ϭ MC6), p,p'-dichlorodiphenyl-dichloroethylene (p,p'-DDE) and hexachlorobenzene (HCB) was performed by gas chromatography-mass spectrometry (GC-MS), running in selected ion monitoring mode, using electron impact or negative chemical ionization. The two most abundant ions of the chlorine cluster of the molecular ion for each compound were measured, as well as one ion for 13 C-labeled internal standards and recovery standards.
For the brominated compounds, the masses 79 and 81 were monitored after ionization by negative chemical ionization. A quantification standard mixture, including all compounds in addition to the internal standards and recovery standards, was used to calculate relative response factors (RRFs). These RRFs were used to calculate the compound levels in the samples. The recovery of the internal standard was calculated as well. All recoveries were between 50% and 120%, and all blank levels were Ͻ10% of the levels reported for all compounds. The levels of detection, defined with a signal to noise (S/N) ratio Ͼ3, were 0.3 to 1 ng/g depending on the compound and the amount of sample. For some PCB congeners, eg, 182/187, both contribute to the concentration found. Because of chemical similarity, it is not possible to resolve the isomers. If some of the PCB congeners were under the detection limit (not detected; n.d.), 50% of the detection limit was used. However, for chlordanes, HCB and DDE, no n. 170/190, 189, 202, 200, 199, 201, 196/203, 195, 194, 208, 207, 206 , and 209.
Statistical Methods
Unconditional logistic regression analysis was performed using the Stata program (Stata/SE 8.2 for Windows; StataCorp, College Station, TX) for calculation of ORs and 95% confidence intervals (CI) for different POPs. In the analyses, adjustment was made for age and BMI at the time of sampling as continuous variables. In one analysis, we adjusted for age as a categorical variable, which yielded somewhat higher ORs, but without any statistically significantly changed results. Thus, the presented results were adjusted for age as a continuous variable. Adjustment was made for family history of prostate cancer but because the results were not significantly changed, unadjusted results are given. The median concentration in the controls was used as cut-off value in the calculations of ORs and CIs because no biological relevant cut-off exists. The Stata program also was used for descriptive statistics and Wilcoxon rank sum tests for calculation of P values.
Analysis of groupings of PCBs according to structural and biological activity was performed. 19 
Results
Almost all patients (90%) agreed to participate in the study. The response rate among the control patients was somewhat lower (80%). Mean and median age for participants was 73 and 74 years, respectively (range, 57-84 years). The corresponding ages for controls were 71 and 72 years (range, 55-80 years). The median level of PSA in subjects was 16.5 ng/mL (mean, 254.5; range, 0.2-6320) and in controls was 4.6 ng/mL (mean, 6.7; range, 0.6 -27; missing value for 4 controls). Table 1 displays concentrations of the analyzed POPs in cases and controls. The concentrations of transchlordane and MC6 were significantly increased among the prostate cancer cases. The concentrations were in general somewhat higher among the cases also for most of the other analyzed POPs, although not statistically significantly higher in the total study population. However, in the case group with a PSA greater than 16.5 ng/mL, the concentrations of PCB 153, HCB, p,p'-DDE, transchlordane, MC6, trans-nonachlordane, and sum of chlordanes were statistically significantly higher than among the control subjects (P Ͻ 0.05).
ORs for PCB 153 and transchlordane were significantly higher for the cases ( Table 2 ). Calculation of ORs in the two groups of cases based on median PSA level yielded increased ORs for most of the pesticides for those cases with PSA greater than 16.5 ng/mL, significantly so for PCB 153, HCB, transchlordane, and MC6. However, for cis-heptachloroepoxide and sum of PBDEs, no such pattern of risk increase was found. The results were not significantly changed when adjustment was made for clinical stage, Gleason score, or nuclear grade (data not shown).
In Table 3 , results are given based on grouping of PSA levels in the cases based on somewhat more clinical relevance. The results in the case group with PSA greater than 10 ng/mL was similar as in the group with PSA greater than16.5 ng/mL (Table 2) , although with lower ORs. However, the results in the group with PSA 4 -10 ng/mL were based on very low numbers of cases.
Grouping of PCB congeners in the high PSA group (PSA Ͼ16.5 ng/mL) according to the method of Wolff et al 19 produced significantly increased risks for enzyme-inducing PCBs (OR ϭ 4.97, 95% CI ϭ 1.25-19.8; Table 4 ). The grouping of lower chlorinated PCB congeners in accordance with Moysich et al 20 yielded OR ϭ 3.75, 95% CI ϭ 1.01-13.9 in the same category.
In addition, the method for the grouping of PCB congeners given by McFarland and Clarke 21 resulted in increased ORs in the case group with PSAs greater than 16.5 ng/mL, significantly for known and predicted phenobarbital inducers with OR ϭ 4.97, 95% CI ϭ 1.25-19.8.
Regarding TEQ, somewhat increased ORs were found in the case group with PSA greater than 16.5 ng/mL (Table 4) . Grouping of cases according to PSA levels in three categories yielded similar results (Table 5 ). However, the result for group 1-lower chlorinated PCBs according to Moysich et al 23 -was no longer statistically significant.
Discussion
Our main finding in this study was an association between certain persistent organic pollutants and prostate cancer, significantly so for PCB 153 and trans-chlordane in the total study population. PCB 153 is the congener with the highest concentration of all PCB congeners. 13, 14 Thus, PCB 153 may be used as a marker for PCB exposure. For most of the studied POPs, OR increased further in the case group with PSA greater than 16.5 ng/mL. However, it must be pointed out that the results are suggestive for an association given the broad CIs and the arbitrary cutoff point of PSA.
Prostate cancer is the most common cancer type among men in the Western world. The etiology is largely unknown. The incidence of prostate cancer has increased substantially since 1997, mainly because of increased PSA testing. 3 The mean age at diagnosis in Sweden is 73 years, 23 which is in agreement with the mean age in our study.
Prostate cancer is hormonally related, and PCB congeners may act with estrogenic, antiestrogenic, and dioxin-like effects based on level of chlorination and molecular configuration. 9 We grouped PCB congeners based on proposed biological activity.
Grouping of PCBs according to Wolff et al 19 gave highest OR for enzyme-inducing PCBs, which is in agreement with the results of Ritchie et al. 9 In that study, increased ORs also were presented for moderately chlorinated PCBs grouped according to Moysich et al. 20 We found increased OR for both lower and moderately chlorinated PCBs. Grouping of PCBs based on McFarland and Clarke 21 showed highest OR for phenobarbital inducers, which is similar to results by Ritchie et al. 9 It should be noted that in a recent study on mice exposure to estrogen in the neonatal period affected prostate growth and gave an increased incidence of prostate intraepithelial lesion in late life. 24 Endocrine disrupting properties also have been shown for hexachlorobenzene, p,p'-DDE, and chlordanes, as we have discussed elsewhere. 25, 26 We also found increased ORs for these POPs. All results were lipid based, and adjustments were made for BMI. The sum of PBDEs was not increased or affected by PSA level, and this fact also argues against disease bias.
The mechanism for POPs as potential risk factors for prostate cancer is unclear. Because they are endocrine disruptors, hormonal activity may be involved in late-stage carcinogenesis. Of course, this hypothesis should be further studied, both in epidemiological and laboratory investigations. Family history is one risk factor for prostate cancer. 27 Three cases and two controls reported at least one first-degree relative with prostate cancer. Adjustment for heredity was made in one analysis, but the results were not statistically significant (data not shown). Few cases had a family history of prostate cancer, probably because of random variation. The median concentration among controls was used as cut-off. Number of cases and controls Ͼ median concentrations are given. Prostate cancer cases were divided in two groups based on median level of PSA (ng/mL). Unconditional logistic regression analysis was used adjusted for age at tissue sampling (ie, diagnosis) and BMI. The median concentration among controls was used as cut-off. Number of cases and controls Ͼ median concentrations are given. Prostate cancer cases were divided in three groups based on clinical relevance of PSA (ng/mL). Unconditional logistic regression analysis was used adjusted for age at tissue sampling (ie, diagnosis) and body mass index.
The Gleason grading system offers valuable prognostic information, 28 and the probability of developing metastasis has been found to increase with increasing Gleason score. 29 Thus, the risk estimates would be expected to increase by more aggressive tumors. However, the risk estimates were not changed by tumor stage or Gleason score in multivariate analyses. This might be the result of the small study number, which provided insufficient power to detect a true difference. We also analyzed risk according to PSA with a cut-off at 16.5 ng/mL and found greater ORs for the different POPs, except for cis-heptachlorepoxide and the sum The median concentration among controls was used as cut-off. Prostate cancer cases were divided in two groups based on median level of PSA (ng/mL). Number of cases and controls Ͼ median concentrations are given. Unconditional logistic regression analysis was used adjusted for age at tissue sampling (ie, diagnosis) and body mass index. PCBs were grouped according to Wolff et al, 19 Moysich et al, 20 McFarland and Clarke, 21 and Ahlborg et al. The median concentration among controls was used as cut-off. Prostate cancer cases were divided in two groups based on median level of PSA (ng/mL). Number of cases and controls Ͼ median concentrations are given. Unconditional logistic regression analysis was used adjusted for age at tissue sampling (ie, diagnosis) and BMI. PCBs were grouped according to Wolff et al, 19 Moysich et al, 20 McFarland and Clarke, 21 and Ahlborg et al. 22 of PBDEs, in the case group with PSAs greater than 16.5 ng/mL than in the group with PSAs 16.5 ng/mL or less. Clinically, it is unclear what this PSA cut-off value implies, besides the median value among the cases. The PSA level is correlated with tumor burden. However, a PSA value greater than 16.5 ng/mL is not considered equivalent with advanced tumor stage, and we have no obvious explanation for this finding. We also grouped cases according to PSA levels of more biological relevance. The results were similar in the case group with highest PSA (Ͼ10 ng/mL) as in the group with PSA level greater than 16.5 ng/mL. In this study, the concentration of most of the analyzed POPs was somewhat higher in the cases than in the controls. No subject reported occupational exposure to the studied chemicals. One possibility for the higher concentration in the cases might be weight loss because of the disease. However, mean BMI in the cases (25.54) was not significantly different from the controls (26.33; P ϭ 0.35). We analyzed also BMI in the cases 1 year before diagnosis, ie, time of adipose tissue sampling, (BMI ϭ 25.78) and found no significant difference with the current index (BMI ϭ 25.54; P ϭ 0.07). Thus, it is unlikely that the results were explained by weight loss among the cases. Furthermore, we divided the cases in two groups based on median PSA level. In the group of cases with PSAs 16.5 ng/mL or less, mean BMI at diagnosis was 26.18 and 1 year before diagnosis 26.41 (P ϭ 0.09). For cases with PSAs greater than 16,5 ng/mL, the results were 24.90 and 25.15 (P ϭ 0.28), respectively. It is thus unlikely that the results regarding concentrations of POPs were explained by loss of weight among the cases.
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Some methodological limitations of this study have to be considered, and the results must be interpreted with caution. First, the number of cases and controls is low and, thus, the power of the study is limited. Second, there is an imbalance regarding the number of cases and controls, with only 20 subjects turning out to have a benign prostate hyperplasia. Thus, this low number of controls did not permit grouping of the concentrations of POPs in quartiles. In one analysis, we categorized certain organochlorines in tertiles without considering PSA level. This yielded in the highest tertile for PCB 153 OR ϭ 3.39, 95% CI ϭ 0.87-13.2, P for trend ϭ 0.56; for trans-chlordane OR ϭ 4.55, 95% CI ϭ 1.07-19.4, P for trend ϭ 0.40; and for MC6 OR ϭ 2.92, 95% CI ϭ 0.76 -11.2, P for trend ϭ 0.02.
Furthermore, some difficulties may arise by the selection of patients with benign hyperplasia as controls if common risk factors exist both for prostate cancer and benign hyperplasia, which would bias the results toward unity. On the other hand, the controls constitute a reasonable homogenous group with histopathological confirmation of benign prostate hyperplasia and are similar in many aspects with prostate cancer patients, for instance, age distribution. This is valid at least for the recruiting time period (1997) (1998) (1999) , where no screening activity for prostate cancer took place.
This study has also some strengths; the population-based design and the high response rate among both cases and controls. All adipose tissue samples got an id number, and it was not disclosed until statistical analysis if it was a case or a control. It is thus unlikely that the results were influenced by observational bias.
In conclusion, this study provided indications that prostate cancer may be related to certain persistent organic pollutants. It should be noted, however, that the results in this study were based on low numbers, especially for the controls, and the findings must be interpreted with caution. Certainly, these results stimulate to further research on this topic.
